相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy
Roddy Walsh et al.
GENOME MEDICINE (2019)
Mutation profile of FLNC gene and its prognostic relevance in patients with hypertrophic cardiomyopathy
Hao Cui et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Roddy Walsh et al.
GENETICS IN MEDICINE (2017)
Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction
Karol Miszalski-Jamka et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients
Juan Gomez et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
Yigal M. Pinto et al.
EUROPEAN HEART JOURNAL (2016)
Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C
Eyal Reinstein et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy
Andreas Brodehl et al.
HUMAN MUTATION (2016)
Genetic basis of dilated cardiomyopathy
Alexandra Perez-Serra et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Martin F. Ortiz-Genga et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy
Rafael Valdes-Mas et al.
NATURE COMMUNICATIONS (2014)
Filamin C-related myopathies: pathology and mechanisms
Dieter O. Fuerst et al.
ACTA NEUROPATHOLOGICA (2013)
Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro
Misato Fujita et al.
DEVELOPMENTAL BIOLOGY (2012)
Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy
R Jenni et al.
HEART (2001)
Structural and functional aspects of filamins
A van der Flier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)
Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein
TG Thompson et al.
JOURNAL OF CELL BIOLOGY (2000)